Mallinckrodt lands oral oxycodone, acetaminophen patent; U. of Illinois-Chicago researchers develop nanoscale targeted anti-inflammatory drugs;

> Mallinckrodt ($MNK) collected a patent for its extended-release oral oxycodone and acetaminophen for twice-daily dosing to treat acute pain. It makes use of Depomed's Acuform delivery tech. Release

> Researchers at the University of Illinois at Chicago have developed nanoparticles that target rogue immune cells with anti-inflammatory drugs, while leaving healthy immune cells unharmed. Release

> W.L. Gore touted successful results from its Revise clinical study for its Viabahn Endoprosthesis with Haparin Bioactive Surface. The study showed that it worked better than a percutaneous transluminal angioplasty to treat stenoses or thrombotic occlusions. Release

Suggested Articles

Zosano will need to run additional studies and await an FDA inspection to address the agency's complete response letter on its migraine patch Qtrypta.

Nanoform Finland tapped Quotient Sciences to help run the first in-human trial of a drug developed using its 'nanoforming' technology later this year.

Swiss scientists are using ultrasound to trap and deliver drugs in the brain, a non-invasive delivery method that could help target tumors, too.